This time at I/O, Google appeared to get the upper hand, vibe-wise, with a flurry of new models and features, a vision of a ...

Devindra has been writing about the way technology intersects with our lives for nearly 20 years. He started the Amherst ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

Huang’s comments came as the truce between the U.S. and China over tariffs and semiconductors continues to be delicate.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Cursor is a fork of Visual Studio Code rebuilt from the ground up for AI-assisted development. It looks and feels like VS ...

The two efforts were awarded $500,000 research grants each in collaboration with Novant Health, UNC Health and the University of North Carolina at Chapel Hill School of Medicine.

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...